Media Advisory: The Men’s Event Benefitting Prostate Cancer Research
Posted in News Release
WASHINGTON — Last year, nearly 239,000 men were diagnosed with prostate cancer, and according to the American Cancer Society (new window), about 30,000 men died from the disease. On Monday, June 23, for the 15th year, prominent Washington, DC-area businessmen will gather for The Men’s Event to support prostate cancer research happening at Georgetown Lombardi Comprehensive Cancer Center (new window).
Georgetown Lombardi physicians will kick off this year’s event with an exciting announcement about recent developments in prostate cancer treatment. The dramatic results of a clinical trial involving Georgetown Lombardi patients, announced just days ago, could translate into longer survival for men with advanced disease.
Last year, 175 attendees helped (new window) raise $150,000 to advance treatment and laboratory research.
WHAT: The Men’s Event
WHEN: Monday, June 23, 2014
5:30 p.m. — Prostate cancer research briefing
6:00 to 7:00 p.m. — Cocktails
7:15 p.m. — Dinner program and auction
WHERE: The Capital Grill, 5310 Western Avenue, Chevy Chase, Maryland, 20815
Physician presenters: Georgetown Lombardi Director Louis M. Weiner, MD, Deputy Director Michael B. Atkins, MD, and radiation oncologist Anatoly Dritschilo, MD, Georgetown Lombardi Comprehensive Cancer Center
PARKING: Self and valet parking is available in the garage beneath Bloomingdale’s on Friendship Blvd.
Presented by: K & L Gates and the National Cancer Prevention Fund
Master of Ceremonies: Leon Harris, WJLA Channel 7 news anchor
Event co-chairs: Clifford J. Alexander of K&L Gates, LLP
Floyd (Skip) Davis III of Floyd E. Davis Company
Mark O. Decker of BMO Capital Markets
Bradford F. Englander of Whiteford Taylor & Preston, LLP
H. Jason Gold of Wiley Rein, LLP
Paul S. Schweitzer of Serten Advisors, LLC
Vic Seested III of UBS Private Wealth Management
Louis M. Weiner, MD, of Georgetown Lombardi Comprehensive Cancer Center
Media RSVP: Sarah Reik, firstname.lastname@example.org (Media invited to attend from 5:30 to 7:00 pm)
About Georgetown Lombardi Comprehensive Cancer Center
Georgetown Lombardi Comprehensive Cancer Center, part of Georgetown University Medical Center and MedStar Georgetown University Hospital, seeks to improve the diagnosis, treatment, and prevention of cancer through innovative basic and clinical research, patient care, community education and outreach, and the training of cancer specialists of the future. Georgetown Lombardi is one of only 41 comprehensive cancer centers in the nation, as designated by the National Cancer Institute (grant #P30 CA051008), and the only one in the Washington, DC area. For more information, go to http://lombardi.georgetown.edu (new window).
About Georgetown University Medical Center
Georgetown University Medical Center is an internationally recognized academic medical center with a three-part mission of research, teaching and patient care (through MedStar Health). GUMC’s mission is carried out with a strong emphasis on public service and a dedication to the Catholic, Jesuit principle of cura personalis — or “care of the whole person.” The Medical Center includes the School of Medicine and the School of Nursing & Health Studies, both nationally ranked; Georgetown Lombardi Comprehensive Cancer Center, designated as a comprehensive cancer center by the National Cancer Institute; and the Biomedical Graduate Research Organization (BGRO), which accounts for the majority of externally funded research at GUMC including a Clinical Translation and Science Award from the National Institutes of Health.